Annual Drug Patent Expirations for SUNOSI
Sunosi is a drug marketed by Axsome Malta and is included in one NDA. It is available from two suppliers. There are twenty-three patents protecting this drug.
Drug patent litigation for SUNOSI.
This drug has sixty patent family members in twenty-three countries.
The generic ingredient in SUNOSI is solriamfetol hydrochloride. Two suppliers are listed for this compound. Additional details are available on the solriamfetol hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com